• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23369 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) SentiMag and Sienna+ system for sentinel lymph node biopsy in breast cancer
2016     NIHR Health Services and Delivery Research programme Equity of utilisation of cardiovascular care and mental health services in England: a cohort-based cross-sectional study using small-area estimation
2016     Institute for Clinical Effectiveness and Health Policy (IECS) Three-dimensional electroanatomical mapping in arrhythmia ablation
2016     HAYES, Inc. Nitric oxide breath analysis for the management of asthma
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brivaracetam - Benefit assessment according to §35a Social Code Book V]
2016     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Ga-68 prostate specific membrane antigen (PSMA) PET/CT
2016     NIHR Horizon Scanning Centre (NIHR HSC) AXS 02 (zoledronic acid) for type I complex regional pain syndrome
2016     HAYES, Inc. Noninvasive computed fractional flow reserve from computed tomography (FFRCT) for coronary artery disease
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vismodegib - Benefit assessment according §35a Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Blinatumomab (Blincyto) for B-precursor acute lymphoblastic leukaemia minimal residual disease – patients in remission
2016     HAYES, Inc. Noninvasive electrical bone growth stimulators for spinal fusion or foot and ankle indications
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cobimetinib: addendum to commission A15-52]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Duvelisib for relapsed chronic lymphocytic leukaemia – second and subsequent line
2016     HAYES, Inc. Patient-specific instruments for total knee arthroplasty: a review of reviews
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Sacubitril/valsartan: addendum to commission A15-60]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Duvelisib for relapsed follicular lymphoma - third and subsequent line
2016     HAYES, Inc. Ultrasound-guided high-intensity focused ultrasound for primary treatment of localized prostate cancer
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Rilpivirine (new therapeutic indication): addendum to commisison A15-55]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lenvatinib (Lenvima) for unresectable hepatocellular carcinoma – first line
2016     HAYES, Inc. 5-aminolevulinic acid photodynamic therapy versus carbon dioxide laser ablation for the treatment of condylomata acuminata
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Crizotinib: addendum to commission A15-59]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Masitinib for relapsed or refractory peripheral T-cell lymphoma
2016     HAYES, Inc. Amniotic tissue–derived allografts for treatment of plantar fasciitis
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide: addendum to commission A15-61]
2016     NIHR Health Technology Assessment programme The Head Injury Transportation Straight to Neurosurgery (HITS-NS) randomised trial: a feasibility study
2016     NIHR Health Services and Delivery Research programme Outpatient services and primary care: scoping review, substudies and international comparisons
2016     HAYES, Inc. Bupivacaine liposome injectable suspension (Exparel; Pacira Pharmaceuticals Inc.) for treatment of postoperative pain in abdominal surgeries
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ramucirumab (new therapeutic indication): benefit assessment according to §35a Social Code Book V]
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ursodeoxycholic acid (Ursofalk®)
2016     HAYES, Inc. Carbon dioxide (CO2) laser ablation versus other surgical treatment of condylomata acuminata
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Empagliflozin: benefit assessment according to §35a Social Code Book V]
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Eribulin mesilate (Halaven®)
2016     HAYES, Inc. Fecal microbiota transplant for refractory or recurrent Clostridium difficile infection in adults
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Empagliflozin/metformin: benefit assessment according to §35a Social Code Book V]
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sorafenib (Nexavar®)
2016     HAYES, Inc. Intersitial brachytherapy for the treatment of nonmelanoma skin cancer
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ramucirumab (new therapeutic indication): benefit assessment according to §35a Social Code Book V]
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ulipristal acetate (Esmya®)
2016     Agency for Healthcare Research and Quality (AHRQ) Omega-3 fatty acids and cardiovascular disease: an updated systematic review
2016     HAYES, Inc. Laser balloon ablation for treatment of atrial fibrillation
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Osimertinib: benefit assessment according to §35a Social Code Book V]
2016     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Prucalopride (Resolor®)
2016     Agency for Healthcare Research and Quality (AHRQ) Strategies to de-escalate aggressive behavior in psychiatric patients
2016     HAYES, Inc. Low frequency right transcranial magnetic stimulation for major depressive disorder
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib - addendum to commission A16-04]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lefitolimod for extensive small cell lung cancer – maintenance therapy
2016     Health Quality Ontario (HQO) Composite tissue transplant of hand or arm: a health technology assessment
2016     HAYES, Inc. Magnetic resonance-guided focused ultrasound therapy (ExAblate 2000; InSightec Ltd.) for ablation of uterine fibroids
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Necitumumab - Benefit assessment according to §35a Social Code Book V]
2016     NIHR Health Technology Assessment programme Concordance in diabetic foot ulceration: a cross-sectional study of agreement between wound swabbing and tissue sampling in infected ulcers
2016     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of erythropoiesis-stimulating agents (epoetin and darbepoetin) for treating cancer treatment-induced anaemia (including review of technology appraisal no. 142): a systematic review and economic model
2016     NIHR Horizon Scanning Centre (NIHR HSC) Fostamatinib for chronic immune thrombocytopenic purpura
2016     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: a health technology assessment
2016     HAYES, Inc. NanoKnife system for irreversible electroporation treatment of locally advanced pancreatic cancer
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ticagrelor (new therapeutic indication): benefit assessment according to §35a Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Daratumumab with bortezomib and dexamethasone for relapsed or refractory multiple myeloma – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Reparixin for prevention of delayed graft function in pancreatic islet transplantation for type 1 diabetes mellitus
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: a health technology assessment
2016     HAYES, Inc. NanoKnife system for irreversible electroporation treatment of primary and metastatic liver tumors
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idelalisib: benefit assessment according to §35a Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) IMA-901 for locally advanced or metastatic renal cell carcinoma ─ first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Bezlotoxumab for treatment and prevention of recurrence of Clostridium difficile infection
2016     Health Quality Ontario (HQO) Women's experiences of inaccurate breast cancer screening results: a systematic review and qualitative meta-synthesis
2016     HAYES, Inc. Surface brachytherapy for the treatment of nonmelanoma skin cancer
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Mepolizumab - addendum to commission A16-03]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Alicaforsen for active ulcerative colitis – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Cadazolid for treatment of Clostridium difficile-associated diarrhoea
2016     Health Quality Ontario (HQO) Fecal microbiota therapy for clostridium difficile infection: a health technology assessment
2016     HAYES, Inc. UroLift System (NeoTract Inc.) for treatment of benign prostatic hyperplasia
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Non-drug interventions for the treatment of benign prostatic syndrome (BPS)]
2016     NIHR Health Technology Assessment programme Bladder ultrasound for diagnosing detrusor overactivity: test accuracy study and economic evaluation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Fenfluramine for Dravet syndrome – first line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Glecaprevir with pibrentasvir for chronic hepatitis C infection, genotypes 1, 2, 3, 4, 5 and 6
2016     Health Quality Ontario (HQO) Composite tissue transplant of hand or arm: OHTAC recommendation
2016     HAYES, Inc. Verasense (OrthoSensor Inc.) for use during total knee arthroplasty
2016     Andalusian Health Technology Assessment Area (AETSA) [Guide for the preparation of evidence synthesis reports: medicines. Update]
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brivaracetam - addendum to commission A16-08]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Guselkumab for moderate to severe psoriasis
2016     NIHR Horizon Scanning Centre (NIHR HSC) Letermovir for the prevention of cytomegalovirus infection in sero-positive patients undergoing allogeneic haematopoietic stem cell transplantation
2016     Health Quality Ontario (HQO) Retinal prosthesis system for advanced retinitis pigmentosa: OHTAC recommendation
2016     HAYES, Inc. Guardant360 (Guardant Health Inc.)
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Vismodegib - addendum to commission A16-09]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Doxorubicin-eluting beads (DC Bead, DC Bead M1 and Radiopaque DC Bead) for hepatocellular carcinoma
2016     NIHR Horizon Scanning Centre (NIHR HSC) CAM2038 for opioid dependence
2016     Health Quality Ontario (HQO) Ultrasound as an adjunct to mammography for breast cancer screening: OHTAC recommendation
2016     HAYES, Inc. Oncotype DX DCIS Breast Cancer Test (Genomic Health Inc.)
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Afatinib (new therapeutic indication) - benefit assessment according to §35a Social Code Book V]
2016     NIHR Horizon Scanning Centre (NIHR HSC) Cytovir CMV for cytomegalovirus infection in patients undergoing allogeneic haematopoietic stem cell transplantation
2016     NIHR Horizon Scanning Centre (NIHR HSC) Naloxone single dose nasal spray for opioid overdose
2016     Health Quality Ontario (HQO) Fecal microbiota therapy for clostridium difficile infection: OHTAC recommendation
2016     HAYES, Inc. Oncotype DX Genomic Prostate Score (GPS) Assay (Genomic Health Inc.)
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ramucirumab (colorectal cancer) - Addendum to Commission A16-10]
2016     NIHR Health Technology Assessment programme A randomised trial of the effect and cost-effectiveness of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with screen-detected type 2 diabetes: the Anglo Danish Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe) study
2016     NIHR Horizon Scanning Centre (NIHR HSC) Lenvatinib in combination with everolimus for advanced or metastatic renal cell carcinoma – second line
2016     NIHR Horizon Scanning Centre (NIHR HSC) RGN-259 for neurotrophic keratopathy
2016     HAYES, Inc. Accelerated partial breast irradiation for breast cancer using brachytherapy
2016     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ramucirumab - benefit assessment according to §35a Social Code Book V]
2016     NIHR Health Technology Assessment programme A randomised controlled trial to measure the effects and costs of a dental caries prevention regime for young children attending primary care dental services: the Northern Ireland Caries Prevention In Practice (NIC-PIP) trial
2016     NIHR Horizon Scanning Centre (NIHR HSC) Nivolumab for follicular non-Hodgkin lymphoma ─ third line
2016     NIHR Horizon Scanning Centre (NIHR HSC) Botulinum toxin A (Dysport) for hyperhidrosis of the axillae